J, Z., S, C., Y, H., F, Y., Q, H., & N, X. (2021). Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer. Dove Medical Press.
Cita Chicago Style (17a ed.)J, Zhuang, Chen S, Hu Y, Yang F, Huo Q, y Xie N. Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an SiRNA Against Metastatic Breast Cancer. Dove Medical Press, 2021.
Cita MLA (8a ed.)J, Zhuang, et al. Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an SiRNA Against Metastatic Breast Cancer. Dove Medical Press, 2021.
Precaución: Estas citas no son 100% exactas.